Literature DB >> 22381223

Prospective, randomized in vivo comparison of a dual-active waterless antiseptic versus two alcohol-only waterless antiseptics for surgical hand antisepsis.

Linda K M Olson1, Dan J Morse, Collette Duley, Brenon K Savell.   

Abstract

BACKGROUND: This study aimed to demonstrate the value of adding an active level of a persistent antimicrobial agent, such as chlorhexidine gluconate (CHG), to an alcohol-based surgical hand antiseptic.
METHODS: The persistence of 3 waterless, brushless alcohol-based surgical hand antiseptics, including one product containing CHG, was compared. The test products were applied a total of 12 times over 5 days. Samples of aerobic bacteria were collected on days 1 and 5, on both days immediately after drying and 6 hours later, using the glove juice technique. Relative suppression of regrowth was compared using t tests.
RESULTS: Using an equivalence margin of 20%, the alcohol plus CHG product showed noninferiority to the alcohol-only products at all sampling points and, based on significantly lower bacterial regrowth (P = .026), superior persistence to the alcohol-only products after 6 hours of glove wear.
CONCLUSIONS: Given the primary objective of surgical hand antisepsis of reducing resident skin flora for the duration of the surgical procedure, using an alcohol-based hand antiseptic containing CHG appears to be the most appropriate choice for maintaining microbial levels as low as possible for as long as possible. Copyright Â
© 2012 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22381223     DOI: 10.1016/j.ajic.2011.10.012

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  8 in total

1.  Evaluation of antimicrobial persistent activity of alcohol-based hand antiseptics against bacterial contamination.

Authors:  R M López-Gigosos; E Mariscal-López; M Gutierrez-Bedmar; A García-Rodriguez; A Mariscal
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-01-28       Impact factor: 3.267

2.  Antiseptic Agents Elicit Short-Term, Personalized, and Body Site-Specific Shifts in Resident Skin Bacterial Communities.

Authors:  Adam J SanMiguel; Jacquelyn S Meisel; Joseph Horwinski; Qi Zheng; Charles W Bradley; Elizabeth A Grice
Journal:  J Invest Dermatol       Date:  2018-05-09       Impact factor: 8.551

3.  Comparison of an alcohol-based hand rub and water-based chlorhexidine gluconate scrub technique for hand antisepsis prior to elective surgery in horses.

Authors:  Eduardo Almeida da Silveira; Kirstin A Bubeck; Edisleidy Rodriguez Batista; Perrine Piat; Sheila Laverty; Guy Beauchamp; Marie Archambault; Yvonne Elce
Journal:  Can Vet J       Date:  2016-02       Impact factor: 1.008

Review 4.  Preventing complications in dermatologic surgery: Presurgical concerns.

Authors:  Allen G Strickler; Payal Shah; Shirin Bajaj; Richard Mizuguchi; Rajiv I Nijhawan; Mercy Odueyungbo; Anthony Rossi; Désirée Ratner
Journal:  J Am Acad Dermatol       Date:  2021-01-23       Impact factor: 15.487

5.  Chlorhexidine is not an essential component in alcohol-based surgical hand preparation: a comparative study of two handrubs based on a modified EN 12791 test protocol.

Authors:  Thomas-Jörg Hennig; Sebastian Werner; Kathrin Naujox; Andreas Arndt
Journal:  Antimicrob Resist Infect Control       Date:  2017-09-13       Impact factor: 4.887

Review 6.  Periprosthetic knee infection: ten strategies that work.

Authors:  Javad Parvizi; Priscilla Ku Cavanaugh; Claudio Diaz-Ledezma
Journal:  Knee Surg Relat Res       Date:  2013-11-29

Review 7.  Alcohol-Based Hand Sanitizers in COVID-19 Prevention: A Multidimensional Perspective.

Authors:  Kennedy Abuga; Nasser Nyamweya
Journal:  Pharmacy (Basel)       Date:  2021-03-19

Review 8.  Surgical hand antisepsis to reduce surgical site infection.

Authors:  Judith Tanner; Jo C Dumville; Gill Norman; Mathew Fortnam
Journal:  Cochrane Database Syst Rev       Date:  2016-01-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.